Borealin/CDCA8 deficiency alters thyroid development and results in papillary tumor-like structures

Front Endocrinol (Lausanne). 2023 Oct 27:14:1286747. doi: 10.3389/fendo.2023.1286747. eCollection 2023.

Abstract

Background: BOREALIN/CDCA8 mutations are associated with congenital hypothyroidism and thyroid dysgenesis. Borealin is involved in mitosis as part of the Chromosomal Passenger Complex. Although BOREALIN mutations decrease thyrocyte adhesion and migration, little is known about the specific role of Borealin in the thyroid.

Methods: We characterized thyroid development and function in Borealin-deficient (Borealin +/-) mice using histology, transcriptomic analysis, and quantitative PCR.

Results: Thyroid development was impaired with a hyperplastic anlage on embryonic day E9.5 followed by thyroid hypoplasia from E11.5 onward. Adult Borealin +/- mice exhibited euthyroid goiter and defect in thyroid hormone synthesis. Borealin +/- aged mice had disorganized follicles and papillary-like structures in thyroids due to ERK pathway activation and a strong increase of Braf-like genes described by The Cancer Genome Atlas (TCGA) network of papillary thyroid carcinoma. Moreover, Borealin +/- thyroids exhibited structural and transcriptomic similarities with papillary thyroid carcinoma tissue from a human patient harboring a BOREALIN mutation, suggesting a role in thyroid tumor susceptibility.

Conclusion: These findings demonstrate Borealin involvement in critical steps of thyroid structural development and function throughout life. They support a role for Borealin in thyroid dysgenesis with congenital hypothyroidism. Close monitoring for thyroid cancer seems warranted in patients carrying BOREALIN mutations.

Keywords: Borealin; congenital hypothyroidism; thyroid cancer; thyroid dysgenesis; thyroid function.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Cycle Proteins / genetics
  • Congenital Hypothyroidism* / genetics
  • Mice
  • Thyroid Cancer, Papillary / genetics
  • Thyroid Dysgenesis* / genetics
  • Thyroid Neoplasms* / genetics

Substances

  • CDCA8 protein, human
  • Cell Cycle Proteins
  • CDCA8 protein, mouse

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. HD-M was supported by the non-profit Fonds d’Etudes et de Recherche du Corps Médical (FERCM) and Assistance Publique-Hôpitaux de Paris (AP-HP). AC and MP received financial support from three corporations (EDF, Sandoz SAS, and Merck Serono France). The funders were not involved in the study design, analysis, interpretation of data, the writing of this article or the decision to submit it for publication. AS was supported by a European Society for Paediatric Endocrinology Research Fellowship Grant and by the Alexander S. Onassis Foundation.